Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 87
Filter
Add more filters

Country/Region as subject
Affiliation country
Publication year range
1.
World J Microbiol Biotechnol ; 38(3): 54, 2022 Feb 12.
Article in English | MEDLINE | ID: mdl-35149902

ABSTRACT

Mannosylerythritol lipid-B (MEL-B), which comprises ester-bonded hydrophilic ME and hydrophobic fatty acids, is a bio-surfactant with various unique properties, including antimicrobial activity against most gram-positive bacteria. The gram-positive Staphylococcus aureus is a causative pathogen of dairy cattle mastitis, which results in considerable economic loss in the dairy industry. Here, we demonstrate the efficacy of MEL-B as a disinfectant against bovine-derived S. aureus and elucidate a mechanism of action of MEL-B in the inhibition of bacterial growth. The growth of bovine mastitis causative S. aureus BM1006 was inhibited when cultured with MEL-B above 10 ppm. The activity of MEL-B required fatty acids (i.e., caprylic and myristoleic acids) as ME, the component of MEL-B lacking fatty acids, did not inhibit the growth of S. aureus even at high concentrations. Importantly, ME-bound fatty acids effectively inhibited the growth of S. aureus when compared with free fatty acids. Specifically, the concentrations of ME-bound fatty acids and free caprylic and myristoleic acids required to inhibit the growth of S. aureus were 10, 1442, and 226 ppm, respectively. The involvement of ME in the antimicrobial activity of MEL-B was confirmed by digestion of MEL-B with alkali, which dissociated ME and fatty acids. These results indicated that a mechanism of action of MEL-B in inhibiting the growth of S. aureus could be explained by the effective transporting of antimicrobial fatty acids to the bacterial surface via hydrophilic ME.


Subject(s)
Anti-Infective Agents , Mastitis, Bovine , Staphylococcal Infections , Animals , Anti-Bacterial Agents/pharmacology , Cattle , Female , Glycolipids , Mastitis, Bovine/drug therapy , Microbial Sensitivity Tests , Staphylococcal Infections/drug therapy , Staphylococcal Infections/veterinary , Staphylococcus aureus
2.
Amino Acids ; 53(3): 381-393, 2021 Mar.
Article in English | MEDLINE | ID: mdl-33598768

ABSTRACT

While it has been hypothesized that brown adipocytes responsible for mammalian thermogenesis are absent in birds, the existence of beige fat has yet to be studied directly. The present study tests the hypothesis that beige fat emerges in birds as a mechanism of physiological adaptation to cold environments. Subcutaneous neck adipose tissue from cold-acclimated or triiodothyronine (T3)-treated chickens exhibited increases in the expression of avian uncoupling protein (avUCP, an ortholog of mammalian UCP2 and UCP3) gene and some known mammalian beige adipocyte-specific markers. Morphological characteristics of white adipose tissues of treated chickens showed increased numbers of both small and larger clusters of multilocular fat cells within the tissues. Increases in protein levels of avUCP and mitochondrial marker protein, voltage-dependent anion channel, and immunohistochemical analysis for subcutaneous neck fat revealed the presence of potentially thermogenic mitochondria-rich cells. This is the first evidence that the capacity for thermogenesis may be acquired by differentiating adipose tissue into beige-like fat for maintaining temperature homeostasis in the subcutaneous fat 'neck warmer' in chickens exposed to a cold environment.


Subject(s)
Acclimatization/physiology , Chickens/physiology , Subcutaneous Fat/metabolism , Abdominal Fat/cytology , Abdominal Fat/metabolism , Adipocytes, Beige/metabolism , Adipose Tissue/metabolism , Animals , Body Weight , Cold Temperature , Eating , Mitochondria/metabolism , Neck/physiology , Subcutaneous Fat/cytology , Subcutaneous Fat/drug effects , Thermogenesis/drug effects , Triiodothyronine/pharmacology , Uncoupling Protein 1/genetics , Uncoupling Protein 1/metabolism , Voltage-Dependent Anion Channels/metabolism
3.
J Biol Chem ; 293(26): 10186-10201, 2018 06 29.
Article in English | MEDLINE | ID: mdl-29760187

ABSTRACT

Toll-like receptor 4 (TLR4) is an indispensable immune receptor for lipopolysaccharide (LPS), a major component of the Gram-negative bacterial cell wall. Following LPS stimulation, TLR4 transmits the signal from the cell surface and becomes internalized in an endosome. However, the spatial regulation of TLR4 signaling is not fully understood. Here, we investigated the mechanisms of LPS-induced TLR4 internalization and clarified the roles of the extracellular LPS-binding molecules, LPS-binding protein (LBP), and glycerophosphatidylinositol-anchored protein (CD14). LPS stimulation of CD14-expressing cells induced TLR4 internalization in the presence of serum, and an inhibitory anti-LBP mAb blocked its internalization. Addition of LBP to serum-free cultures restored LPS-induced TLR4 internalization to comparable levels of serum. The secretory form of the CD14 (sCD14) induced internalization but required a much higher concentration than LBP. An inhibitory anti-sCD14 mAb was ineffective for serum-mediated internalization. LBP lacking the domain for LPS transfer to CD14 and a CD14 mutant with reduced LPS binding both attenuated TLR4 internalization. Accordingly, LBP is an essential serum molecule for TLR4 internalization, and its LPS transfer to membrane-anchored CD14 (mCD14) is a prerequisite. LBP induced the LPS-stimulated phosphorylation of TBK1, IKKϵ, and IRF3, leading to IFN-ß expression. However, LPS-stimulated late activation of NF-κB or necroptosis were not affected. Collectively, our results indicate that LBP controls LPS-induced TLR4 internalization, which induces TLR adaptor molecule 1 (TRIF)-dependent activation of the TBK1-IKKϵ-IRF3-IFN-ß pathway. In summary, we showed that LBP-mediated LPS transfer to mCD14 is required for serum-dependent TLR4 internalization and activation of the TRIF pathway.


Subject(s)
Acute-Phase Proteins/metabolism , Carrier Proteins/metabolism , I-kappa B Kinase/metabolism , Interferon Regulatory Factor-3/metabolism , Lipopolysaccharide Receptors/metabolism , Membrane Glycoproteins/metabolism , Protein Serine-Threonine Kinases/metabolism , Toll-Like Receptor 4/metabolism , Humans , Lipopolysaccharides/pharmacology , Lymphocyte Antigen 96/metabolism , Phosphorylation/drug effects , Protein Transport/drug effects
4.
Vet Res ; 49(1): 22, 2018 02 26.
Article in English | MEDLINE | ID: mdl-29482613

ABSTRACT

Staphylococcus aureus is a major pathogen that causes subclinical mastitis associated with huge economic losses to the dairy industry. A few vaccines for bovine mastitis are available, and they are expected to induce the production of S. aureus-specific antibodies that prevent bacterial adherence to host cells or promote opsonization by phagocytes. However, the efficacy of such vaccines are still under debate; therefore, further research focusing on improving the current vaccines by seeking additional mechanisms of action is required to reduce economic losses due to mastitis in the dairy industry. Here, we generated S. aureus-specific bovine IgG antibodies (anti-S. aureus) that directly inhibited bacterial growth in vitro. Inhibition depended on specificity for anti-S. aureus, not the interaction between Protein A and the fragment crystallizable region of the IgG antibodies or bacterial agglutination. An in vitro culture study using S. aureus strain JE2 and its deletion mutant JE2ΔSrtA, which lacks the gene encoding sortase A, revealed that the effect of anti-S. aureus was sortase-A-independent. Sortase A is involved in the synthesis of cell-wall-associated proteins. Thus, other surface molecules, such as membrane proteins, cell surface polysaccharides, or both, may trigger the inhibition of bacterial growth by anti-S. aureus. Together, our findings contribute insights into developing new strategies to further improve the available mastitis vaccine by designing a novel antigen on the surface of S. aureus to induce inhibitory signals that prevent bacterial growth.


Subject(s)
Antibodies, Bacterial/metabolism , Cattle Diseases/immunology , Immunoglobulin G/metabolism , Staphylococcal Infections/veterinary , Staphylococcus aureus/immunology , Animals , Cattle , Male , Staphylococcal Infections/immunology , Staphylococcus aureus/growth & development
5.
Nihon Koshu Eisei Zasshi ; 64(5): 258-269, 2017.
Article in Japanese | MEDLINE | ID: mdl-28626153

ABSTRACT

Objective From April 2008, specific health checkups have been implemented to prevent metabolic syndrome (MetS) and related cardiovascular diseases based on assurance of medical care for the elderly in Japan. In its "Standard Health Checkup and Counseling Guidance Program," 22 standard question items are recommended to assess health conditions of Japanese citizens. However, there are few community-based studies to clarify the relationship between question items and new onset of high risk conditions for cardiovascular diseases such as MetS. Accordingly, we performed a 5-year follow-up study of community dwellers who participated in health checkups of National Health Insurance beneficiaries in Habikino City, Osaka.Method Lifestyle factors assessed by standard question items in 2008 were defined as exposures at baseline survey. In the analysis of MetS, we followed-up 4,720 participants without MetS; and in the analysis of hypertension, we followed-up 3,326 participants without hypertension until the end of March in 2013. New-onset MetS or hypertension during follow-up were defined as outcomes. Cox proportional hazard model was used to evaluate the relationship between lifestyle factors and the incidence of MetS or hypertension after adjustment for age and waist circumference.Results The median follow-up period for incidence of MetS was 3.1 years for men and 3.6 years for women. We observed 570 new cases of MetS during follow-up. For men, "taking dinner within 2 hours before going to sleep" and "body weight increase by 10 kg or greater from 20 years old" were significantly associated with MetS (hazard ratio [HR], 1.43; 95% confidence interval [CI], 1.09-1.88 and HR, 1.33; 95% CI, 1.19-1.75, respectively). Occasional consumption of alcohol in men was negatively associated with MetS. For women, "increase or decrease of body weight by 3 kg or greater within 1 year" and "body weight increase by 10 kg or greater from age of 20" were significantly associated with MetS (HR, 1.83; 95% CI, 1.40-2.40 and HR, 2.02; 95% CI, 1.52-2.68, respectively). Daily alcohol consumption from 1 to less than 2 gou (about 23 to 45 g of ethanol) in women was positively associated with MetS (HR, 2.64; 95% CI, 1.51-4.64). We observed 1,045 new cases of hypertension; however, except for daily alcohol consumption for men, no lifestyle factors were associated with incidence of hypertension.Conclusion Most standard question items of specific health checkups did not predict new-onset MetS or hypertension, at least within 5 years. Thus, development of more predictive question items is warranted.


Subject(s)
Hypertension/epidemiology , Life Style , Metabolic Syndrome/epidemiology , Aged , Cohort Studies , Female , Humans , Incidence , Independent Living , Insurance Benefits , Japan , Male , Middle Aged , National Health Programs , Surveys and Questionnaires
6.
Cell Tissue Res ; 364(3): 585-597, 2016 06.
Article in English | MEDLINE | ID: mdl-26899250

ABSTRACT

Microfold (M) cells in the follicle-associated epithelium (FAE) of Peyer's patches contribute to the mucosal immune response by the transcytosis of microorganisms. The mechanism by which M cells take up microorganisms, and the functional proteins by which they do this, are not clear. In order to explore one such protein, we developed a 2H5-F3 monoclonal antibody (2H5-F3 mAb) through its binding to bovine M cells, and identified the antibody reactive molecule as cyclophilin A (Cyp-A). The localization patterns of Cyp-A were very similar to the localization pattern of cytokeratin (CK) 18-positive M cells. Cyp-A was identified at the luminal surface of CK18-positive M cells in bovine jejunal and ileal FAE. The membranous localization of Cyp-A in the bovine intestinal cell line (BIE cells) increased as cells differentiated toward M cells, as determined by flow cytometry analysis. Additionally, BIE cells released Cyp-A to the extracellular space and the differentiation of BIE cells to M cells increased the secretion of Cyp-A, as determined by western blotting. Accordingly, Cyp-A may be localized in M cells in the small intestinal epithelium of cattle. The rise of the membranous localization and secretion of Cyp-A by differentiation toward M cells indicates that Cyp-A has an important role in the function of M cells. While Cyp-A of the M cell membrane may contribute to the uptake of viruses with peptidyl-prolyl cis-trans isomerase activity, in the extracellular space Cyp-A may work as a chemokine and contribute to the distribution of immuno-competent cells.


Subject(s)
Cyclophilin A/metabolism , Intestinal Mucosa/cytology , Intestinal Mucosa/metabolism , Animals , Antibodies, Monoclonal/metabolism , Biomarkers/metabolism , Cattle , Cell Differentiation , Chromatography, Liquid , Colon/cytology , Duodenum/cytology , Ileum/cytology , Immunohistochemistry , Immunoprecipitation , Jejunum/cytology , Male , Mice, Inbred BALB C , Microvilli/metabolism , Nasopharynx/cytology , Peptides/analysis , Peyer's Patches/cytology , Peyer's Patches/ultrastructure , Tandem Mass Spectrometry
7.
Vet Res ; 46: 80, 2015 Jul 11.
Article in English | MEDLINE | ID: mdl-26163364

ABSTRACT

Cyclophilin A (CyPA) was originally discovered in bovine thymocytes as a cytosolic binding protein of the immunosuppressive drug cyclosporine A. Recent studies have revealed that in mice and humans, CyPA is secreted from cells in injured or infected tissues and plays a role in recruiting inflammatory cells in those tissues. Here we found that in cattle abundant level of extracellular CyPA was observed in tissues with inflammation. To aid in investigating the role of extracellular CyPA in cattle, we generated recombinant bovine CyPA (rbCyPA) and tested its biological activity as an inflammatory mediator. When bovine peripheral blood cells were treated with rbCyPA in vitro, we observed that rbCyPA reacts with the membranous surface of granulocytes, monocytes and lymphocytes. Chemotaxis analysis showed that the granulocytes migrate toward rbCyPA and the migration is inhibited by pre-treatment with an anti-bovine CyPA antibody. These results indicate that, as for mice and humans, extracellular CyPA possesses chemotactic activity to recruit inflammatory cells (e.g., granulocytes) in cattle, and could thus be a potential therapeutic target for the treatment of inflammation.


Subject(s)
Chemotaxis , Cyclophilin A/genetics , Granulocytes/physiology , Mastitis, Bovine/immunology , Animals , Cattle , Cyclophilin A/metabolism , Female , Granulocytes/immunology , Recombinant Proteins/genetics , Recombinant Proteins/metabolism
8.
Cells Tissues Organs ; 198(1): 66-74, 2013.
Article in English | MEDLINE | ID: mdl-23838214

ABSTRACT

Transforming growth factor-ß (TGF-ß) is implicated in the regulatory expression of chemokines that control multiple steps in myogenesis. However, it remains to be established whether myostatin, a member of the TGF-ß superfamily, affects chemokine expression in skeletal muscle. We investigated the effects of myostatin on the expression of mRNAs and proteins for 4 chemokines (CXCL1, CXCL2, CXCL6, CCL2) in intact and regenerating musculus longissimus thoracis from normal-muscled (NM) and double-muscled (DM) cattle. These chemokines were expressed in regenerating muscle, and their expression was always lower in DM than in NM cattle. Immunohistochemistry revealed that CXCL1 and CXCL6 were detected in the regenerating areas of myoblasts and myotubes in both NM and DM cattle. In cultures of myoblasts isolated from the regenerating muscles, significantly less CXCL1, CXCL2 and CCL2 mRNA was expressed in DM myoblasts than in NM myoblasts during the proliferating stage (P-stage). The expression of CXCL1, CXCL2 and CCL2 mRNAs in NM myoblasts and CXCL1, CXCL2 and CXCL6 mRNAs in DM myoblasts decreased upon switching from P-stage to fusion stage (F-stage). Also, the expression of CXCL1, CXCL2 and CXCL6 mRNAs was significantly lower in DM than in NM myoblasts during the F-stage. The addition of 100 ng/ml myostatin during the F-stage attenuated the expression of CXCL1 and CXCL2 mRNAs and augmented that of CCL2. These results show for the first time that myostatin regulates the differential expression of chemokines in skeletal muscle cells.


Subject(s)
Chemokines/genetics , Gene Expression Regulation, Developmental , Muscle, Skeletal/physiology , Muscle, Skeletal/ultrastructure , Myostatin/metabolism , Regeneration , Animals , Cattle , Cell Proliferation , Cells, Cultured , Chemokines/analysis , Muscle Development , Muscle, Skeletal/metabolism , Myoblasts/cytology , Myoblasts/metabolism , RNA, Messenger/genetics
9.
Am J Pathol ; 179(3): 1301-9, 2011 Sep.
Article in English | MEDLINE | ID: mdl-21763679

ABSTRACT

Transmissible spongiform encephalopathies are fatal neurodegenerative diseases. Infection by the oral route is assumed to be important, although its pathogenesis is not understood. Using prion protein (PrP) knockout mice, we investigated the sequence of events during the invasion of orally administered PrPs through the intestinal mucosa and the spread into lymphoid tissues and the peripheral nervous system. Orally administered PrPs were incorporated by intestinal epitheliocytes in the follicle-associated epithelium and villi within 1 hour. PrP-positive cells accumulated in the subfollicle region of Peyer's patches a few hours thereafter. PrP-positive cells spread toward the mesenteric lymph nodes and spleen after the accumulation of PrPs in the Peyer's patches. The number of PrP molecules in the mesenteric lymph nodes and spleen peaked at 2 days and 6 days after inoculation, respectively. The epitheliocytes in the follicle-associated epithelium incorporating PrPs were annexin V-positive microfold cells and PrP-positive cells in Peyer's patches and spleen were CD11b-positive and CD14-positive macrophages. Additionally, PrP-positive cells in Peyer's patches and spleen were detected in the vicinity of peripheral nerve fibers in the early stages of infection. These results indicate that orally delivered PrPs were incorporated by microfold cells promptly after challenge and that macrophages might act as a transporter of incorporated PrPs from the Peyer's patches to other lymphoid tissues and the peripheral nervous system.


Subject(s)
Brain/metabolism , Intestinal Mucosa/metabolism , Macrophages/metabolism , Peyer's Patches/metabolism , Prions/pharmacokinetics , Administration, Oral , Animals , Immunohistochemistry , Intestine, Small/metabolism , Lymph Nodes/metabolism , Male , Mesentery/metabolism , Mice , Mice, Knockout , Peyer's Patches/pathology , Prion Diseases/etiology , Prions/administration & dosage , Spleen/metabolism
10.
J Nutr Biochem ; 99: 108855, 2022 01.
Article in English | MEDLINE | ID: mdl-34517096

ABSTRACT

Patients with inflammatory bowel disease (IBD) have higher incidence of extraintestinal manifestations (EIM), including liver disorders, sarcopenia, and neuroinflammation. Fermented rice bran (FRB), generated from rice bran (RB), is rich in bioactive compounds, and exhibits anti-colitis activity. However, its role in EIM prevention is still unclear. Here, for the first time, we investigated whether EIM in female C57Bl/6N mice is attenuated by FRB supplementation. EIM was induced by repeated administration of 1.5% dextran sulfate sodium (DSS) in drinking water (4 d) followed by drinking water (12 d). Mice were divided into 3 groups-control (AIN93M), 10% RB, and 10% FRB. FRB ameliorated relapsing colitis and inflammation in muscle by significantly lowering proinflammatory cytokines Tnf-α and Il-6 in serum and advanced glycation end product-specific receptor (Ager) in serum and muscle when compared with the RB and control groups. As FRB reduced aspartate aminotransferase levels and oxidative stress, it might prevent liver disorders. FRB downregulated proinflammatory cytokine and chemokine transcripts responsible for neuroinflammation in the hippocampus and upregulated mRNA expression of G protein coupled receptors (GPRs), Gpr41 and Gpr43, in small and large intestines, which may explain the FRB-mediated protective mechanism. Hence, FRB can be used as a supplement to prevent IBD-associated EIM.


Subject(s)
Colitis/drug therapy , Colitis/immunology , Dietary Fiber/administration & dosage , Oryza/chemistry , Plant Preparations/administration & dosage , Animals , Chemokines/genetics , Chemokines/immunology , Chronic Disease/therapy , Colitis/chemically induced , Colitis/genetics , Dextran Sulfate/adverse effects , Dietary Fiber/analysis , Dietary Supplements/analysis , Disease Models, Animal , Female , Hippocampus/immunology , Humans , Interleukin-6/genetics , Interleukin-6/immunology , Intestines/immunology , Male , Mice , Mice, Inbred C57BL , Muscle, Skeletal/immunology , Oxidative Stress , Tumor Necrosis Factor-alpha/genetics , Tumor Necrosis Factor-alpha/immunology
11.
Anim Sci J ; 93(1): e13764, 2022.
Article in English | MEDLINE | ID: mdl-36085592

ABSTRACT

Mastitis is a very common inflammatory disease of the mammary gland of dairy cows, resulting in a reduction of milk production and quality. Probiotics may serve as an alternative to antibiotics to prevent mastitis, and the use of probiotics in this way may lessen the risk of antibiotic resistant bacteria developing. We investigated the effect of oral feeding of probiotic Bacillus subtilis (BS) C-3102 strain on the onset of mastitis in dairy cows with a previous history of mastitis. BS feeding significantly decreased the incidence of mastitis, the average number of medication days and the average number of days when milk was discarded, and maintained the mean SCC in milk at a level substantially lower than the control group. BS feeding was associated with lower levels of cortisol and TBARS and increased the proportion of CD4+ T cells and CD11c+ CD172ahigh dendritic cells in the blood by flow cytometry analysis. Parturition increased the migrating frequency of granulocytes toward a milk chemoattractant cyclophilin A in the control cows, however, this was reduced by BS feeding, possibly indicating a decreased sensitivity of peripheral granulocytes to cyclophilin A. These results reveal that B. subtilis C-3102 has potential as a probiotic and has preventative capacity against mastitis in dairy cows.


Subject(s)
Cattle Diseases , Mastitis, Bovine , Probiotics , Animals , Anti-Bacterial Agents/therapeutic use , Bacillus subtilis , Cattle , Cyclophilin A , Female , Mastitis, Bovine/prevention & control
12.
J Cell Physiol ; 226(4): 1128-36, 2011 Apr.
Article in English | MEDLINE | ID: mdl-20945337

ABSTRACT

The transforming growth factor (TGF)-ß inducible early gene (TIEG)-1 is implicated in the control of cell proliferation, differentiation, and apoptosis in some cell types. Since TIEG1 functioning may be associated with TGF-ß, a suppressor of myogenesis, TIEG1 is also likely to be involved in myogenesis. Therefore, we investigated the function of TIEG1 during myogenic differentiation in vitro using the murine myoblasts cell line, C2C12. TIEG1 expression increased during differentiation of C2C12 cells. Constitutive expression of TIEG1 reduced survival and decreased myotube formation. Conversely, knocking down TIEG1 expression increased the number of viable cells during differentiation, and accelerated myoblast fusion into multinucleated myotubes. However, expression of the myogenic differentiation marker, myogenin, remained unaffected by TIEG1 knockdown. The mechanism underlying these events was investigated by focusing on the regulation of myoblast numbers after induction of differentiation. The knockdown of TIEG1 led to changes in cell cycle status and inhibition of apoptosis during the initial stages of differentiation. Microarray and real-time PCR analyses showed that the regulators of cell cycle progression were highly expressed in TIEG1 knockdown cells. Therefore, TIEG1 is a negative regulator of the myoblast pool that causes inhibition of myotube formation during myogenic differentiation.


Subject(s)
Cell Differentiation , DNA-Binding Proteins/metabolism , Muscle Development , Myoblasts/cytology , Myoblasts/metabolism , Transcription Factors/metabolism , Animals , Apoptosis , Cell Count , Cell Cycle , Cell Cycle Proteins/genetics , Cell Cycle Proteins/metabolism , Cell Differentiation/genetics , Cell Fusion , Cell Line , DNA-Binding Proteins/genetics , Gene Knockdown Techniques , Mice , Muscle Development/genetics , Muscle Fibers, Skeletal/cytology , Muscle Fibers, Skeletal/metabolism , Myogenin/genetics , Myogenin/metabolism , Transcription Factors/genetics , Up-Regulation/genetics
13.
Am J Physiol Gastrointest Liver Physiol ; 300(3): G442-53, 2011 Mar.
Article in English | MEDLINE | ID: mdl-21193527

ABSTRACT

Microfold (M) cells in the follicle-associated epithelium (FAE) of Peyer's patches have an important role in mucosal immune responses. A primary difficulty for investigations of bovine M cells is the lack of a specific molecular marker. To identify such a marker, we investigated the expression of several kinds of intermediate filament proteins using calf Peyer's patches. The expression patterns of cytokeratin (CK) 18 in jejunal and ileal FAE were very similar to the localization pattern of M cells recognized by scanning electron microscopy. Mirror sections revealed that jejunal CK18-positive cells had irregular and sparse microvilli, as well as pocket-like structures containing lymphocytes, typical morphological characteristic of M cells. However, CK18-negative cells had regular and dense microvilli on their surface, typical of the morphology of enterocytes. In contrast, CK20 immunoreactivity was detected in almost all villous epithelial cells and CK18-negative cells in the FAE. CK18-positive proliferating transit-amplifying cells in the crypt exchanged CK18 for CK20 above the mouth of the crypt and after moving to the villi; however, CK18-positive M cells in the crypt continued their expression of CK18 during movement to the FAE region. Terminal deoxynucleotidyl-transferase-mediated deoxyuridine-triphosphate-biotin nick-end labeling-positive apoptotic cells were specifically detected at the apical region of villi and FAE in the jejunum and ileum, and all were also stained for CK20. These data indicate that CK18 may be a molecular marker for bovine M cells in FAE and that M cells may transdifferentiate to CK20-positive enterocytes and die by apoptosis in the apex of the FAE.


Subject(s)
Enterocytes/metabolism , Ileum/metabolism , Intestinal Mucosa/metabolism , Jejunum/metabolism , Keratin-18/metabolism , Peyer's Patches/metabolism , Age Factors , Animals , Apoptosis , Biomarkers/metabolism , Cattle , Cell Proliferation , Cell Transdifferentiation , Colon/metabolism , Duodenum/metabolism , Enterocytes/ultrastructure , Ileum/cytology , Immunohistochemistry , In Situ Nick-End Labeling , Intestinal Mucosa/cytology , Jejunum/cytology , Keratin-20/metabolism , Male , Microscopy, Electron, Scanning , Microvilli/metabolism , Peyer's Patches/cytology
14.
Nutrients ; 13(6)2021 May 30.
Article in English | MEDLINE | ID: mdl-34070845

ABSTRACT

Fermented rice bran (FRB) is known to protect mice intestines against dextran sodium sulfate (DSS)-induced inflammation; however, the restoration of post-colitis intestinal homeostasis using FRB supplementation is currently undocumented. In this study, we observed the effects of dietary FRB supplementation on intestinal restoration and the development of fibrosis after DSS-induced colitis. DSS (1.5%) was introduced in the drinking water of mice for 5 days. Eight mice were sacrificed immediately after the DSS treatment ended. The remaining mice were divided into three groups, comprising the following diets: control, 10% rice bran (RB), and 10% FRB-supplemented. Diet treatment was continued for 2 weeks, after which half the population of mice from each group was sacrificed. The experiment was continued for another 3 weeks before the remaining mice were sacrificed. FRB supplementation could reduce the general observation of colitis and production of intestinal pro-inflammatory cytokines. FRB also increased intestinal mRNA levels of anti-inflammatory cytokine, tight junction, and anti-microbial proteins. Furthermore, FRB supplementation suppressed markers of intestinal fibrosis. This effect might have been achieved via the canonical Smad2/3 activation and the non-canonical pathway of Tgf-ß activity. These results suggest that FRB may be an alternative therapeutic agent against inflammation-induced intestinal fibrosis.


Subject(s)
Diet/methods , Fermentation , Intestinal Diseases/prevention & control , Oryza , Animals , Dextran Sulfate , Dietary Supplements , Disease Models, Animal , Female , Fibrosis , Inflammation/physiopathology , Mice , Mice, Inbred C57BL
15.
Cell Rep ; 36(10): 109655, 2021 09 07.
Article in English | MEDLINE | ID: mdl-34496253

ABSTRACT

The evolutionary strategy of transferring maternal antibodies via milk profoundly impacts the survival, lifelong health, and wellbeing of all neonates, including a pronounced impact on human breastfeeding success and infant development. While there has been increased recognition that interorgan connectivity influences the quality of a mother's milk, potentially to personalize it for her offspring, the underlying bases for these processes are incompletely resolved. Here, we define an essential role of Peyer's patches (PPs) for the generation of plasma cells that secrete maternal immunoglobulin A (IgA) into milk. Our metagenomic analysis reveals that the presence of certain residential microorganisms in the gastrointestinal (GI) tract, such as Bacteroides acidifaciens and Prevotella buccalis, is indispensable for the programming of maternal IgA synthesis prior to lactational transfer. Our data provide important insights into how the microbiome of the maternal GI environment, specifically through PPs, can be communicated to the next generation via milk.


Subject(s)
Gastrointestinal Microbiome/immunology , Intestinal Mucosa/immunology , Milk, Human/immunology , Plasma Cells/cytology , Animals , Humans , Immunoglobulin A/immunology , Immunoglobulin A, Secretory/immunology , Mice , Peyer's Patches/immunology
16.
Biochem Biophys Res Commun ; 393(4): 762-6, 2010 Mar 19.
Article in English | MEDLINE | ID: mdl-20171187

ABSTRACT

Myostatin and TGF-beta negatively regulate skeletal muscle development and growth. Both factors signal through the Smad2/3 pathway. However, the regulatory mechanism of myostatin and TGF-beta signaling remains unclear. TGF-beta inducible early gene (TIEG) 1 is highly expressed in skeletal muscle and has been implicated in the modulation of TGF-beta signaling. These findings prompted us to investigate the effect of TIEG1 on myostatin and TGF-beta signaling using C2C12 myoblasts. Myostatin and TGF-beta induced the expression of TIEG1 and Smad7 mRNAs, but not TIEG2 mRNA, in proliferating C2C12 cells. When differentiating C2C12 myoblasts were stimulated by myostatin, TIEG1 mRNA was up-regulated at a late stage of differentiation. In contrast, TGF-beta enhanced TIEG1 expression at an early stage. Overexpression of TIEG1 prevented the transcriptional activation of Smad by myostatin and TGF-beta in both proliferating or differentiating C2C12 cells, but the expression of Smad2 and Smad7 mRNAs was not affected. Forced expression of TIEG1 inhibited myogenic differentiation but did not cause more inhibition than the empty vector in the presence of myostatin or TGF-beta. These results demonstrate that TIEG1 is one possible feedback regulator of myostatin and TGF-beta that prevents excess action in myoblasts.


Subject(s)
DNA-Binding Proteins/metabolism , Feedback, Physiological , Muscle Development , Myoblasts/physiology , Myostatin/metabolism , Transcription Factors/metabolism , Transforming Growth Factor beta/metabolism , Animals , Cell Line , DNA-Binding Proteins/genetics , Mice , Myoblasts/metabolism , Myostatin/genetics , Signal Transduction , Smad Proteins/metabolism , Transcription Factors/genetics , Transforming Growth Factor beta/genetics
17.
J Immunol ; 181(9): 6073-81, 2008 Nov 01.
Article in English | MEDLINE | ID: mdl-18941196

ABSTRACT

Stem/Progenitor cells in the postnatal pituitary gland are embedded in a marginal cell layer around Rathke's pouch. However, the nature and behavior of anterior pituitary progenitor cells remain unclear. We established bovine anterior pituitary progenitor cell line (BAPC)-1 from the anterior pituitary gland, which expressed stem/progenitor cell-related genes and several inflammatory cytokines. To characterize and localize these pituitary progenitor cells, we produced a mAb (12B mAb) against BAPC-1. The 12B mAb recognized the 4Ig-B7-H3 molecule, which is a costimulatory molecule and negative regulator in T cell activation. WC1(+) gammadelta T cells in young bovine PBMC express the 4Ig-B7-H3 molecule, but few or no 4Ig-B7-H3-immunoreactive cells are expressed in PBMC in adult cattle. The 12B-immunoreactive cells in the bovine anterior pituitary gland were localized around Rathke's pouch and expressed IL-18 and MHC class II. However, the number of 12B-immunoreactive cells was lower in adult than in young cattle. BAPC-1 expressed IL-18 and MHC class II, and demonstrated phagocytotic activity. BAPC-1 also had the ability to promote CD25 expression in PBMC after 5 days of coculture, and blocking 4Ig-B7-H3 x 12B mAb enhanced their expression of CD25. In addition, the 12B-immunoreactive cells were observed around the pars tuberalis closely bordering the median eminence and in the blood vessels of the primary portal plexus in the anterior pituitary gland. These results suggest that an established BAPC-1 may originate from these progenitor cells, and that the progenitor cells with 4Ig-B7-H3 may play a critical role in the immunoendocrine network.


Subject(s)
Antigens, CD/genetics , Pituitary Gland, Anterior/immunology , Pituitary Gland, Anterior/metabolism , Receptors, Immunologic/genetics , Stem Cells/immunology , Stem Cells/metabolism , Amino Acid Sequence , Animals , Antigens, CD/biosynthesis , Antigens, CD/chemistry , B7 Antigens , Cattle , Female , Male , Mice , Mice, Inbred BALB C , Molecular Sequence Data , Neuroendocrine Cells/immunology , Neuroendocrine Cells/metabolism , Pituitary Gland, Anterior/cytology , RNA, Messenger/biosynthesis , Receptors, Immunologic/biosynthesis , Receptors, Immunologic/chemistry , Sequence Homology, Amino Acid
18.
Front Immunol ; 11: 604674, 2020.
Article in English | MEDLINE | ID: mdl-33424851

ABSTRACT

Morphogenesis and differentiation of organs is required for subsequent functional maturation. The morphological features of Peyer's patches vary among species. In pigs, they develop extensively in the ileum as ileal Peyer's patches (IPPs). However, the role of IPPs in the porcine immune system remains to be elucidated because of a lack of complete understanding of IPP organogenesis. Results of the present study revealed that development of porcine IPPs is initiated prenatally between embryonic days 76 and 91. The process of IPP organogenesis is concomitant with increased transcriptional patterns of CXCL13 and CCL19. IPPs undergo further development postnatally by forming central, marginal, and subepithelial zones. Importantly, a large number of proliferating B cells and apoptotic cells are found in porcine IPPs postnatally, but not prenatally. The expression level of IgM in proliferating B cells depends on the zone in which distinct B cells are separately localized after birth. Specifically, IgM+ cells are predominantly found in the central zone, whereas IgM-/low cells are abundant in the marginal zone. Importantly, the cellular feature of IPPs differs from that of mesenteric lymph nodes (MLNs) where such distinct zones are not formed both prenatally and postnatally. Our findings suggest that IPPs (not MLNs) in postnatal pigs are involved in complementing functions of the primary lymphoid tissue that promotes the differentiation and maturation of B cells.


Subject(s)
B-Lymphocytes/immunology , Cell Differentiation , Cell Proliferation , Ileum/embryology , Peyer's Patches/embryology , Age Factors , Animals , Animals, Newborn , Apoptosis , B-Lymphocytes/metabolism , Chemokine CCL19/genetics , Chemokine CCL19/metabolism , Chemokine CXCL13/genetics , Chemokine CXCL13/metabolism , Female , Gene Expression Regulation, Developmental , Gestational Age , Ileum/immunology , Ileum/metabolism , Immunoglobulin M/metabolism , Organogenesis , Peyer's Patches/immunology , Peyer's Patches/metabolism , Pregnancy , Sus scrofa , T-Lymphocytes/immunology , T-Lymphocytes/metabolism , Time Factors
19.
Nutrients ; 12(8)2020 Aug 12.
Article in English | MEDLINE | ID: mdl-32806520

ABSTRACT

Fermented rice bran (FRB), a prospective supplement, has been proven to ameliorate certain medical conditions. However, its nutraceutical effect on muscle atrophy has never been investigated. The present study aimed to evaluate the effect of FRB on muscle atrophy in a streptozotocin (STZ)-induced diabetic rat model. Three groups of Sprague-Dawley rats, namely the control, STZ, and FRB groups, were treated as follows. The diabetic groups (STZ and FRB) were injected intraperitoneally with STZ (40 mg/kg BW), whereas the control group was injected with the vehicle. The STZ and control groups were fed the AIN93M diet, and the FRB group was fed 10% of FRB based on the AIN93M diet. The diabetic groups had reduced muscle size compared to the control group; however, these changes were alleviated in the FRB group. Moreover, the FRB group had a significantly lower expression of FBXO32/Atrogin-1 and TRIM63/MuRF1 (p < 0.05) due to blocked NF-κB activation. In conclusion, the anti-inflammatory effect of FRB may be beneficial for ameliorating muscle atrophy in diabetic conditions.


Subject(s)
Diabetes Mellitus, Experimental/physiopathology , Dietary Supplements , Muscular Atrophy/diet therapy , Oryza , Animal Feed/analysis , Animals , Anti-Inflammatory Agents , Diabetes Mellitus, Experimental/complications , Fermentation , Male , Muscular Atrophy/etiology , Muscular Atrophy/physiopathology , Rats , Rats, Sprague-Dawley , Streptozocin
20.
Anim Sci J ; 91(1): e13450, 2020.
Article in English | MEDLINE | ID: mdl-32881233

ABSTRACT

Mycoplasma pneumonia of swine (MPS) is caused by Mycoplasma hyopneumoniae (M.hp) and is a common chronic respiratory disease of pigs. Recently, a genetically selected variant of the Landrace pig (Miyagino L2) has a lower incidence of pulmonary MPS lesions. We investigated the pathological and immunological characteristics of MPS resistance in these pigs (n = 24) by comparing with the normal landrace pig (control: n = 24). The pathological MPS lung lesion score in MPS-selected landrace pigs was significantly lower than in the control. The gene expression of interleukin (IL)-12p40, which acts as a chemoattractant and a component of the bioactive cytokines IL-12 and IL-23, was significantly higher at the hilar lymph nodes, lung, and spleen in MPS-selected landrace pigs than in control landrace pigs, and these were negatively correlated with the macroscopic MPS lung lesion score. In summary, we demonstrate that resistance against MPS in Miyagino L2 pigs is associated with IL-12p40 up-regulation, in comparison with normal landrace pigs without the MPS vaccine. In addition, a comparative study of macroscopic MPS lung lesions and IL-12p40 gene expression in lung and hilar lymph nodes may lead to beneficial selection traits for the genetic selection for MPS resistance in pigs.


Subject(s)
Interleukin-12 Subunit p40/genetics , Interleukin-12 Subunit p40/metabolism , Lung/immunology , Lymph Nodes/immunology , Pneumonia of Swine, Mycoplasmal/genetics , Pneumonia of Swine, Mycoplasmal/immunology , Swine/genetics , Swine/immunology , Animals , Gene Expression , Genetic Predisposition to Disease , Male , Quantitative Trait, Heritable , Selection, Genetic , Up-Regulation/genetics
SELECTION OF CITATIONS
SEARCH DETAIL